Trial Profile
A study on the efficacy of combination therapy of insulin and ipragliflozin in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 May 2016 Status changed from active, no longer recruiting to completed.
- 12 Aug 2014 New trial record